Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of nicardipine and esmolol is used primarily to manage hemodynamic responses during medical procedures, particularly to blunt blood pressure and heart rate increases during laryngoscopy and tracheal intubation. This combination leverages the complementary mechanisms of these two drugs to provide better blood pressure control than either agent alone. ## Pharmacological Properties Nicardipine is a dihydropyridine calcium channel blocker that primarily affects vascular smooth muscle, causing vasodilation and reducing blood pressure. It works by inhibiting the influx of extracellular calcium across myocardial and vascular smooth muscle cell membranes. Esmolol is a short-acting beta-blocker that reduces heart rate and contractility by blocking beta-adrenergic receptors in the heart. The combination of these two medications provides more effective blood pressure control during procedures than either drug used individually. ## Clinical Applications The primary use of this combination is in anesthesia and critical care settings, particularly: - **Perioperative blood pressure management**: Studies have shown that the combination of nicardipine and esmolol is more effective at blunting the peak increase in blood pressure after laryngoscopy and tracheal intubation compared to either drug alone. - **Acute aortic dissection management**: The combination can be used as part of initial medical management for aortic dissection, with esmolol controlling heart rate and nicardipine reducing blood pressure. ## Efficacy and Safety Research has demonstrated that when used in combination (even at half doses of each drug), nicardipine and esmolol provide superior blood pressure control compared to full doses of either medication alone. However, it's worth noting that neither the combination nor the individual drugs were completely effective at preventing increases in heart rate during procedures in some studies. Both drugs can have additive effects in lowering blood pressure and heart rate, which may cause side effects such as headache, dizziness, and lightheadedness. Careful monitoring is required when administering this combination. ## Hemodynamic Effects The combination affects various cardiac parameters: - Reduces blood pressure and rate-pressure load - Esmolol can increase minimal lumen diameter - Nicardipine may be associated with negative remodeling of distal segments For specific clinical scenarios like postcraniotomy emergence hypertension, nicardipine has been found to be more effective as a sole agent than esmolol, though the combination provides complementary benefits in many situations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nicardipine and Esmolol combination.